MED-EL SONNET 3 has officially been launched in India during CIGICON 2026 in Agra, marking a major milestone for cochlear implant users nationwide. The global hearing implant leader announced the arrival of its newest behind-the-ear (BTE) audio processor at the annual conference of the Cochlear Implant Group of India (CIGI), held at the Jaypee Palace Hotel and Convention Centre from September 4th to 6th.
Engineered as the manufacturer’s smallest and lightest BTE audio processor to date, the MED-EL SONNET 3 blends discreet comfort, native direct streaming, and clinical-grade durability for children and adult recipients across the country.
Redefining Hearing Usability: Key Features of SONNET 3
The newly introduced audio processor brings significant industrial design upgrades to patients seeking seamless integration between assistive devices and digital ecosystems.
- Compact and Ergonomic Form: As MED-EL’s smallest BTE processor, SONNET 3 minimizes physical ear fatigue while maximizing retention for daily active wear.
- Integrated Direct Streaming: Eliminates external dongles by streaming phone calls, media, and video meetings directly from compatible Apple iOS and Android smartphones.
- Automatic Sound Management (ASM 3.0): Powered by intelligent dual microphones, the front-end processing automatically adapts to loud or shifting environments, suppressing ambient clutter to elevate speech clarity.
- IP68 Water Resistance: Engineered to withstand moisture, dust, heavy sweat, and unexpected immersion, offering durable protection in humid Indian weather conditions.
- Pediatric-Safe Configuration: Features tamperproof locks, specialized babywear/activewear attachment clips, and visual coil-link indicators, making it exceptionally dependable for young learners in school environments.
- Design Excellence: The processor holds the international Red Dot Design Award 2025, underscoring its functional aesthetics.
Technical Specifications: SONNET 3 at a Glance
| Feature / Metric | Specification Details |
| Product Model | MED-EL SONNET 3 |
| Category | Behind-the-Ear (BTE) Cochlear Implant Audio Processor |
| Waterproof Rating | IP68 Standard (dust-tight and submersion protected) |
| Microphone System | Dual Microphones with Omnidirectional and Directional Modes |
| Audio Processing | Automatic Sound Management (ASM 3.0) + FineHearing coding |
| Direct Streaming | Native Bluetooth Low Energy support for iOS (MFi) & Android (ASHA) |
| Pediatric Safeguards | Tamperproof battery locks, link-check LED indicator, fixation straps |
| Target Audience | Bilateral, unilateral, and bimodal cochlear implant users (Pediatric & Adult) |
Clinical Leadership at CIGICON 2026
The commercial release arrived as CIGICON 2026 brought together top otorhinolaryngology (ENT) surgeons, audiologists, habilitation professionals, and speech-language pathologists from across South Asia. The scientific gathering featured several Padma Shri award-winning ENT surgeons and global authorities who examined surgical techniques, objective fitting protocols, and post-operative speech therapy paradigms.
Addressing delegates, Mr. Prem Ranjan, Director, MED-EL India, highlighted the importance of comprehensive intervention:
“The introduction of SONNET 3 in India is an important step in making advanced hearing technology more accessible to people who rely on cochlear implants in their everyday lives. But technology alone cannot transform outcomes.
For children and adults with severe to profound hearing loss, the journey begins with early identification and the right clinical intervention and continues through rehabilitation and long-term support. At MED-EL, we are committed to working alongside clinicians, implant centres and the wider hearing-care community to strengthen this journey.”
Bridging Global Healthcare Technology and Indian Market Needs
Having satisfied all mandatory regulatory compliance clearances in India, the arrival of SONNET 3 aligns the Indian domestic market with availability across the European Union and North America.
Cochlear implantation is a multidisciplinary continuum extending far past surgical intervention. In emerging markets like India, overall uptake remains contingent on early screening, awareness, financing, surgical infrastructure, and sustained post-operative speech habilitation. MED-EL’s expansion plan targets these exact bottlenecks:
- Expanding Healthcare Footprint: Broadening the availability of cutting-edge hardware across private hospital chains and public welfare-driven health missions.
- Deepening Centre Alliances: Partnering with surgical units and audiology labs to improve mapping services, remote diagnostics, and clinical fitting.
- Lifelong Care Ecosystems: Providing uninterrupted recipient support, replacement spares, and continuous training resources to empower families through their auditory journey.
Headquartered in Innsbruck, Austria, MED-EL operates in more than 140 countries. With the debut of SONNET 3 at CIGICON 2026, the company solidifies its position within India’s medical technology landscape, equipping recipients with modern digital connectivity and discreet, reliable hearing performance.
